Myrexis, Inc. Stock Other OTC
Equities
MYRX
US62856H1077
Biotechnology & Medical Research
Financials (USD)
Sales 2012 | - | Sales 2013 | - | Capitalization | 2.59M |
---|---|---|---|---|---|
Net income 2012 | -31M | Net income 2013 | -11M | EV / Sales 2012 | - |
Net cash position 2012 | 89.38 | Net cash position 2013 | 1.21 | EV / Sales 2013 | - |
P/E ratio 2012 |
-2.21
x | P/E ratio 2013 |
-0.19
x | Employees | - |
Yield 2012 * |
-
| Yield 2013 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 13-01-21 | |
Gary S. Mather
PRN | Corporate Officer/Principal | - | 00-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 13-01-21 |
1st Jan change | Capi. | |
---|---|---|
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.86% | 22.2B | |
-16.53% | 21.23B | |
-8.49% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |